Inhibition of presynaptic release-facilitatory kainate autoreceptors by extracellular cyclic GMP

Journal of Pharmacology and Experimental Therapeutics

Volumn 332, Issue 1, 2010, Pages 210-219

  Cervetto, Chiara ^a   Maura, Guido ^a,b   Marcoli, Manuela ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b National Institute of Neuroscience   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; AUTORECEPTOR; CYCLIC GMP; GLUTAMIC ACID; KAINATE AUTORECEPTOR; KAINIC ACID RECEPTOR; NEUROTRANSMITTER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CEREBELLUM CORTEX; CONTROLLED STUDY; EVOKED CORTICAL RESPONSE; EXTRACELLULAR MATRIX; MALE; NERVE CELL NETWORK; NERVE ENDING; NERVE FIBER; NEUROMODULATION; NEUROPHYSIOLOGY; NEUROTRANSMISSION; NEUROTRANSMITTER UPTAKE; NONHUMAN; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; SYNAPTOSOME;

ANIMALS; ASPARTIC ACID; AUTORECEPTORS; CEREBELLUM; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SPACE; GLUTAMIC ACID; KAINIC ACID; MALE; PRESYNAPTIC TERMINALS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; RECEPTORS, KAINIC ACID; SYNAPTOSOMES;

EID: 73949118707     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.109.154955     Document Type: Article

References (55)

1. Belcher SM and Howe JR (1997) Characterization of RNA editing of the glutamatereceptor subunits GluR5 and GluR6 in granule cells during cerebellar development. Brain Res Mol Brain Res 52:130-138.
2. Bortolotto ZA, Clarke VR, Delany CM, Parry MC, Smolders I, Vignes M, Ho KH, Miu P, Brinton BT, Fantaske R, Ogden A, Gates M, Ornstein PL, Lodge D, Bleakman D, and Collingridge GL (1999) Kainate receptors are involved in synaptic plasticity. Nature 402:297-301.
3. Boxall AR and Garthwaite J (1996) Long-term depression in rat cerebellum requires both NO synthase and NO-sensitive guanylyl cyclase. Eur J Neurosci 8:2209-2212.
4. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
5. Campiani G, Morelli E, Nacci V, Fattorusso C, Ramunno A, Novellino E, Greenwood J, Liljefors T, Griffiths R, Sinclair C, et al (2001) Characterization of the 1Hcyclopentapyrimidine-2,4(1H,3H)-dione derivative (S)-CPW399 as a novel, potent, and subtype-selective AMPA receptor full agonist with partial desensitization-preventing properties. J Med Chem 44:4501-4504.
6. Crepel F (2007) Developmental changes in retrograde messengers involved in depolarization-induced suppression of excitation at parallel fiber-Purkinje cell synapses in rodents. J Neurophysiol 97:824-836.
7. Cui C and Mayer ML (1999) Heteromeric kainate receptors formed by the coassembly of GluR5, GluR6, and GluR7. J Neurosci 19:8281-8291.
8. Daniel H, Levenes C, and Crépel F (1998) Cellular mechanisms of cerebellar LTD. Trends Neurosci 21:401-407.
9. Delaney AJ and Jahr CE (2002) Kainate receptors differentially regulate release at two parallel fiber synapses. Neuron 36:475-482.
10. Fedele E and Raiteri M (1999) In vivo studies of the cerebral glutamate receptor/ NO/cGMP pathway. Prog Neurobiol 58:89-120.
11. Feligioni M, Holman D, Haglerod C, Davanger S, and Henley JM (2006) Ultrastructural localisation and differential agonist-induced regulation of AMPA and kainate receptors present at the presynaptic active zone and postsynaptic density. J Neurochem 99:549-560.
12. Francis SH, Blount MA, Zoraghi R, and Corbin JD (2005) Molecular properties of mammalian proteins that interact with cGMP: protein kinases, cation channels, phosphodiesterases, and multi-drug anion transporters. Front Biosci 10:2097-2117.
13. Garthwaite J (2008) Concepts of neural nitric oxide-mediated transmission. Eur J Neurosci 27:2783-2802.
14. Garthwaite J, Southam E, Boulton CL, Nielsen EB, Schmidt K, and Mayer B (1995) Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol Pharmacol 48:184-188.
15. Gonzá lez DR, Fernández IC, Ordenes PP, Treuer AV, Eller G, and Boric MP (2008) Differential role of S-nitrosylation and the NO-cGMP-PKG pathway in cardiac contractility. Nitric Oxide 18:157-167.
16. Hartell NA (2001) Receptors, second messengers and protein kinases required for heterosynaptic cerebellar long-term depression. Neuropharmacology 40:148-161.
17. Hartell NA, Furuya S, Jacoby S, and Okada D (2001) Intercellular action of nitric oxide increases cGMP in cerebellar Purkinje cells. Neuroreport 12:25-28.
18. Honda A, Adams SR, Sawyer CL, Lev-Ram V, Tsien RY, and Dostmann WR (2001) Spatiotemporal dynamics of guanosine 3′,5′-cyclic monophosphate revealed by a genetically encoded, fluorescent indicator. Proc Natl Acad Sci U S A 98:2437-2442.
19. Honoré T, Davies SN, Drejer J, Fletcher EJ, Jacobsen P, Lodge D, and Nielsen FE (1988) Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists. Science 241:701-703.
20. Israël M and Whittaker VP (1965) The isolation of mossy fibre endings from the granular layer of the cerebellar cortex. Experientia 21:325-326.
21. Ito M and Karachot L (1992) Protein kinases and phosphatase inhibitors mediating long-term desensitization of glutamate receptors in cerebellar Purkinje cells. Neurosci Res 14:27-38.
22. Jacoby S, Sims RE, and Hartell NA (2001) Nitric oxide is required for the induction and heterosynaptic spread of long-term potentiation in rat cerebellar slices. J Physiol 535:825-839.
23. Kenakin TP (1992) Tissue response as a functional discriminator of receptor heterogeneity: effects of mixed receptor populations on Schild regressions. Mol Pharmacol 41:699-707.
24. Levenes C, Daniel H, and Crepel F (2001) Retrograde modulation of transmitter release by postsynaptic subtype 1 metabotropic glutamate receptors in the rat cerebellum. J Physiol 537:125-140.
25. Linden DJ, Dawson TM, and Dawson VL (1995) An evaluation of the nitric oxide/ cGMP/cGMP-dependent protein kinase cascade in the induction of cerebellar longterm depression in culture. J Neurosci 15:5098-5105.
26. Luo D, Leung E, and Vincent SR (1994) Nitric oxide-dependent efflux of cGMP in rat cerebellar cortex: an in vivo microdialysis study. J Neurosci 14:263-271.
27. Marcoli M, Cervetto C, Paluzzi P, Guarnieri S, Raiteri M, and Maura G (2006a) Nitric oxide-evoked glutamate release and cGMP production in cerebellar slices: control by presynaptic 5-HT1D receptors. Neurochem Int 49:12-19.
28. Marcoli M, Maura G, Cervetto C, Giacomini C, Oliveri D, Candiani S, and Pestarino M (2006b) Nitric oxide-evoked cGMP production in Purkinje cells in rat cerebellum: an immunocytochemical and pharmacological study. Neurochem Int 49:683-690.
29. Marcoli M, Cervetto C, Paluzzi P, Guarnieri S, Alloisio S, Thellung S, Nobile M, and Maura G (2008) P2X(7) pre-synaptic receptors in adult rat cerebrocortical nerve terminals: a role in ATP-induced glutamate release. J Neurochem 105:2330-2342.
30. Migani P, Fiorini R, Ferretti E, Manini E, Chimichi S, and Moneti G (1997) Role of guanine nucleotides as endogenous ligands of a kainic acid binding site population in the mammalian cerebellum. J Neurochem 68:1648-1654.
31. Montoliu C, Llansola M, Kosenko E, Corbalán R, and Felipo V (1999) Role of cyclic GMP in glutamate neurotoxicity in primary cultures of cerebellar neurons. Neuropharmacology 38:1883-1891.
32. Nakamura Y, Iga K, Shibata T, Shudo M, and Kataoka K (1993) Glial plasmalemmal vesicles: a subcellular fraction from rat hippocampal homogenate distinct from synaptosomes. Glia 9:48-56.
33. Paas Y, Devillers-Thiéry A, Changeux JP, Medevielle F, and Teichberg VI (1996) Identification of an extracellular motif involved in the binding of guanine nucleotides by a glutamate receptor. EMBO J 15:1548-1556.
34. Pedrazzi M, Raiteri L, Bonanno G, Patrone M, Ledda S, Passalacqua M, Milanese M, Melloni E, Raiteri M, Pontremoli S, et al. (2006) Stimulation of excitatory amino acid release from adult mouse brain glia subcellular particles by high mobility group box 1 protein. J Neurochem 99:827-838.
35. Pemberton KE, Belcher SM, Ripellino JA, and Howe JR (1998) High-affinity kainatetype ion channels in rat cerebellar granule cells. J Physiol 510:401-420.
36. Perkinton MS and Sihra TS (1999) A high-affinity presynaptic kainate-type glutamate receptor facilitates glutamate exocytosis from cerebral cortex nerve terminals (synaptosomes). Neuroscience 90:1281-1292.
37. Pinheiro PS, Rodrigues RJ, Rebola N, Xapelli S, Oliveira CR, and Malva JO (2005) Presynaptic kainate receptors are localized close to release sites in rat hippocampal synapses. Neurochem Int 47:309-316.
38. Pittaluga A, Bonfanti A, and Raiteri M (1997) Differential desensitization of ionotropic non-NMDA receptors having distinct neuronal location and function. Naunyn Schmiedebergs Arch Pharmacol 356:29-38.
39. Poulopoulou C and Nowak LM (1998) Extracellular 3,5 cyclic guanosine monophosphate inhibits kainate-activated responses in cultured mouse cerebellar neurons. J Pharmacol Exp Ther 286:99-109.
40. Qiu DL and Knöpfel T (2007) An NMDA receptor/nitric oxide cascade in presynaptic parallel fiber-Purkinje neuron long-term potentiation. J Neurosci 27:3408-3415.
41. Raiteri M, Maura G, Bonanno G, and Pittaluga A (1986) Differential pharmacology and function of two 5-HT1 receptors modulating transmitter release in rat cerebellum. J Pharmacol Exp Ther 237:644-648.
42. Rodríguez-Moreno A and Sihra TS (2004) Presynaptic kainate receptor facilitation of glutamate release involves protein kinase A in the rat hippocampus. J Physiol 557:733-745.
43. Sager G (2004) Cyclic GMP transporters. Neurochem Int 45:865-873.
44. Shabb JB and Corbin JD (1992) Cyclic nucleotide-binding domains in proteins having diverse functions. J Biol Chem 267:5723-5726.
45. Siggins GR, Henriksen SJ, and Landis SC (1976) Electrophysiology of Purkinje neurons in the weaver mouse: iontophoresis of neurotransmitters and cyclic nucleotides, and stimulation of the nucleus locus coeruleus. Brain Res 114:53-69.
46. Smith TC, Wang LY, and Howe JR (1999) Distinct kainate receptor phenotypes in immature and mature mouse cerebellar granule cells. J Physiol 517:51-58.
47. + or N-methyl-N-nitro-N-nitrosoguanidine. Neurosci Lett 68:95-99.
48. Tsuyama S, Yamazaki E, Tomita T, Ihara H, Takenaka S, Kato K, and Kozaki S (1999) Characterization of a novel monoclonal antibody that senses nitric oxide-dependent activation of soluble guanylate cyclase. FEBS Lett 455:291-294.
49. Verdoorn TA, Johansen TH, Drejer J, and Nielsen EO (1994) Selective block of recombinant glur6 receptors by NS-102, a novel non-NMDA receptor antagonist. Eur J Pharmacol 269:43-49.
50. Vollenweider FX, Cuénod M, and Do KQ (1990) Effect of climbing fiber deprivation on release of endogenous aspartate, glutamate, and homocysteate in slices of rat cerebellar hemispheres and vermis. J Neurochem 54:1533-1540.
51. Wilding TJ and Huettner JE (1995) Differential antagonism of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-preferring and kainate-preferring receptors by 2,3-benzodiazepines. Mol Pharmacol 47:582-587.
52. Wong LA and Mayer ML (1993) Differential modulation by cyclothiazide and concanavalin A of desensitization at native alpha-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid- and kainate-preferring glutamate receptors. Mol Pharmacol 44:504-510.
53. Wood PL and Rao TS (1991) A review of in vivo modulation of cerebellar cGMP levels by excitatory amino acid receptors: role of NMDA, quisqualate and kainate subtypes. Prog Neuropsychopharmacol Biol Psychiatry 15:229-235.
54. Zhang W, St-Gelais F, Grabner CP, Trinidad JC, Sumioka A, Morimoto-Tomita M, Kim KS, Straub C, Burlingame AL, Howe JR, and Tomita S (2009) A transmembrane accessory subunit that modulates kainate-type glutamate receptors. Neuron 61:385-396.
55. Ziolo MT (2008) The fork in the nitric oxide road: cyclic GMP or nitrosylation? Nitric Oxide 18:153-156.